Switch to:
More From Other Websites
Apple Drives Selloff on April's Last Trading Day Apr 29 2016
Stocks Sell Off in Final Trading Day of April Apr 29 2016
What Are Analysts Saying About Q1 At Biotech's Big 4? Amgen, Biogen, Celgene, Gilead Apr 29 2016
ADAM KOPPEL, EXECUTIVE VICE PRESIDENT, STRATEGY AND BUSINESS DEVELOPMENT, TO RETURN TO BAIN CAPITAL Apr 29 2016
BIOGEN INC. Files SEC form 8-K, Other Events Apr 29 2016
Biogen and AbbVie Receive Positive Opinion from the CHMP on ZINBRYTA™ (Daclizumab) for Treatment... Apr 29 2016
7:40 am Biogen and AbbVie (ABBV) announce the EMA adopted a... Apr 29 2016
Biogen and AbbVie Receive Positive Opinion from the CHMP on ZINBRYTA™ (Daclizumab) for Treatment... Apr 29 2016
Biogen, AbbVie multiple sclerosis drug wins EU green light Apr 29 2016
ETF’s with exposure to Biogen, Inc. : April 28, 2016 Apr 28 2016
Biotech Boom May Continue Through Earnings Season Apr 28 2016
Tysabri Reports Strong Patient Growth in 1Q16 Apr 28 2016
The Zacks Analyst Blog Highlights: Biogen, Sarepta, Catalyst Pharmaceuticals, AbbVie and Gilead Apr 28 2016
Biotech Stock Roundup: Biogen Tops on Q1 Earnings, Sarepta, Catalyst Plunge on Regulatory News Apr 27 2016
BIOGEN INC. Financials Apr 27 2016
Why Biogen Is Poaching This Pfizer Exec to Head Up Its R&D Shop Apr 27 2016
Biogen Appoints Michael Ehlers Executive Vice President, Research and Development Apr 27 2016
Biogen, Inc. :BIIB-US: Earnings Analysis: Q1, 2016 By the Numbers Apr 27 2016
Biogen Appoints Michael Ehlers Executive Vice President, Research and Development Apr 27 2016
4 Biotech Stocks Reporting on Apr 28: AMGN, GILD, ALXN, CELG Apr 27 2016
Short Sellers Run for Cover From Major Biotechs Apr 27 2016
Biogen’s Hemophilia Drugs Continue to Capture Market Share in 1Q16 Apr 26 2016
Biogen Is Ready to Rise After a 10-Month Downward Spiral Apr 26 2016
Tecfidera Continues to Be Key Revenue Driver for Biogen in 1Q16 Apr 25 2016
How Did Biogen Perform in 1Q16? Apr 25 2016
Biogen beats 1Q profit forecasts Apr 21 2016
Biogen Reports First Quarter 2016 Revenues of $2.7 Billion Apr 21 2016
Data Presented at AAN Highlight Impact of ZINBRYTA™ (Daclizumab HYP) on Cognitive Outcomes and the... Apr 20 2016
TECFIDERA® Data Confirm Strong and Sustained Efficacy in Newly Diagnosed MS Patients and Real-World... Apr 18 2016
Biogen Joins in Celebration of World Hemophilia Day Apr 14 2016
Biogen Data at 2016 AAN Annual Meeting Highlight Its Expansive Portfolio of MS Therapies That Meets... Apr 12 2016
Samsung brings in the lawyers for biosimilars push Apr 03 2016
Biogen Appoints Michel Vounatsos Executive Vice President, Chief Commercial Officer Mar 30 2016
Biogen to Report First Quarter 2016 Financial Results on April 21, 2016 Mar 21 2016
Sobi and Biogen Receive Positive Opinion from CHMP for Alprolix® (rFIXFc) for the Treatment of... Feb 26 2016
Biogen Joins Pioneering Target Validation Collaboration Feb 08 2016
Biogen 4Q profit falls on costs, but tops forecasts Jan 27 2016
Biogen 2015 Revenues Increase 11% to $10.8 Billion Jan 27 2016
Samsung Bioepis Enters the European Biopharmaceutical Market with Benepali®, the First Fusion... Jan 16 2016
Jacobs Wins Contract with Biogen Jan 05 2016
Biogen to Report Fourth Quarter and Year End 2015 Financial Results on January 27, 2016 Dec 21 2015
Sobi and Biogen’s ELOCTA® (rFVIIIFc) Approved in Europe for the Treatment of Haemophilia A Nov 24 2015
Sobi and Biogen's Elocta® (rFVIIIFc) approved in Europe for the treatment of haemophilia A Nov 24 2015
Biogen Announces Benepali™ (Etanercept) is the First Biosimilar of Enbrel® to Receive a Positive... Nov 20 2015
In the Caribbean, a stinking seaweed menace spurs invention Nov 17 2015
Steven Holtzman to Retire from Biogen Nov 11 2015
Regulus Achieves All Research Milestones in Collaboration with Biogen to Identify microRNA... Oct 28 2015
Biogen to cut 11% of its workforce Oct 21 2015
Biogen cutting 11 percent of its workforce Oct 21 2015
US open: Stocks edge higher as investors analyse raft of mixed earnings Oct 21 2015
Biogen tops Street 3Q forecasts Oct 21 2015
US STOCKS-Wall St slides to end rough week on macro, earnings concerns Jul 24 2015
Biogen cuts 2015 profit outlook as key MS drug sales slow Jul 24 2015
US STOCKS-Wall St set to extend selloff Jul 24 2015
Biogen beats 2Q profit forecasts Jul 24 2015
BUZZ-U.S. STOCKS ON THE MOVE-Apple, Intuitive Surgical, Biogen Jul 22 2015
US STOCKS-Nasdaq hits 15-year high, propelled by Amazon, Microsoft Apr 24 2015
US STOCKS-Nasdaq hits 15-year high, propelled by Amazon, Microsoft Apr 24 2015
Biogen misses Street 1Q forecasts Apr 24 2015
FDA approves generic version of top-selling MS drug Copaxone Apr 17 2015
U.S. prescription drug spending rose 13 pct in 2014-IMS report Apr 13 2015
US stocks lifted by Shell, pharma deal news Apr 08 2015
US STOCKS-Wall Street down for 2nd straight day; energy weak Mar 24 2015
US STOCKS-Wall St drifts lower; Google buoys Nasdaq Mar 24 2015
Exclusive - Biogen shortens name, expands ambitions in Alzheimer's, ALS Mar 23 2015
Biogen shares soar on optimistic Alzheimer's drug study data Mar 20 2015
Biogen releases Alzheimer's drug data Mar 20 2015
GLOBAL MARKETS-U.S. stocks slip, dollar gains day after Fed view Mar 19 2015
Biogen tops 4Q profit forecasts Jan 29 2015
Big Pharma faces up to new price pressure from aggressive insurers Jan 15 2015
Insight - Big Pharma faces up to new price pressure from aggressive insurers Jan 15 2015
Big Pharma faces up to new price pressure from aggressive insurers Jan 15 2015
Biogen to buy private U.K. company with chronic pain drug Jan 11 2015
US STOCKS-Wall St set to climb for second day after claims data Jan 08 2015
US STOCKS-Dow ends above 18k for first time on strong GDP report Dec 23 2014
US STOCKS-GDP lifts Dow over 18k; biotechs have worst day since April Dec 23 2014
US STOCKS-Energy shares lead Wall St higher; telecoms slip Dec 02 2014
US STOCKS-Wall St inches lower with healthcare shares Nov 14 2014
Biogen beats Street 3Q forecasts Oct 22 2014
FDA approves Biogen's MS drug Plegridy Aug 15 2014


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK